Skip to main content
Premium Trial:

Request an Annual Quote

Consortium Wins $11.7M Grant from European Commission to Uncover Biomarkers for MI

NEW YORK, Feb. 3 (GenomeWeb News) - The European Commission's Sixth Research Framework Programme has provided a four-year, €9 million ($11.7 million) grant to a research consortium that hopes to discover genetic markers associated with a risk of myocardial infarction and clot formation, according to the University of Cambridge.


The 14 memebrs of the consortium, called "Bloodomics," have set up the European Cardiovascular Genetics Foundation to manage the project, according to the school. Bloodomics will include researchers from the Universityof Cambridgein the UK; Domantis, a UK-based antibody company; Trium Analysis Online, a German informatics company; and the national blood services of the UKand The Netherlands. At least 180 investigators will work as part of Bloodomics.


Research will focus initially on the genes and proteins controlling platelets, with the eventual goal of producing new drugs for the prevention and treatment of heart disease.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.